• / Free eNewsletters & Magazine
  • / My Account


  1. All
  2. Morningstar Articles
  3. Investing
  1. We See Major Upside Potential for InterMune's Shares

    Blockbuster sales and takeover potential create an attractive risk/reward tradeoff for this speculative biotech.

  2. Don't Bail on Biotech

    We see opportunity as fleeing investors trigger an irrational sell-off.

  3. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  4. The Market's Most Overvalued Stocks

    Fancy names can't make up for bad businesses.

©2017 Morningstar Advisor. All right reserved.